All posts tagged leukemia

  • AML.Cells

    “Dramatic” Early Phase 1 Results for AG-120 in IDH1 Mutated AML

    “Extremely promising” early phase 1 clinical trial results for the investigational drug AG-120 against the subset of patients with acute myeloid leukemia (AML) harboring mutations in the gene IDH1.

James DeGregori, Team In Training
Leukemia Cells
Stephen Hunger,
Jing H. Wang, MD, PhD, investigator at the University of Colorado Cancer Center is the recipient of a prestigious American Society of Hematology Scholar Award
Cancer cells are like prarie dogs -- when a first-line cancer drug plugs the front dooor, cancer cells evolve to find other escapes. Photo courtesy of Flickr user gripso_banana_prune, CC license.